Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

IN BRIEF: Angle raises GBP20.0 million to fund FDA approval drive

25th Jun 2021 14:08

Angle PLC - Surrey-based medical diagnostic equipment company - Raises GBP20.0 million through a placing of 17.2 million shares prices at 116 pence each. Issue price is a discount of 6.8% to the closing price on Wednesday of 124.50p, before the offer was announced. Placing shares represent 7.4% of the company's stock.

The money will be used to commercialise the company's Parsortix system and open market opportunities in prostate cancer diagnosis.

Angle will announce progress on "multiple fronts" in the second half of 2021, "including the prospect of FDA clearance for the Parsortix system."

Current stock price: 127.00 pence

Year-to-date change: up 166%

By Ivan Edwards; [email protected]

Copyright 2021 Alliance News Limited. All Rights Reserved.


Related Shares:

Angle
FTSE 100 Latest
Value8,809.74
Change53.53